Soligenix, Inc(NASDAQ:SNGX) 
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a no...
Website: http://www.soligenix.com
Founded: 1987
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.07
H 2.08
L 1.68
C 1.84
V 52,912
10EMA 1.84
20EMA 1.84
60EMA 1.84
120EMA 1.84
250EMA 1.84